Option chain shows key data for Skinvisible's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Skinvisible.

Skinvisible (OTC:SKVI) Stock, Option Chain

Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. The Company is also exploring new opportunities in large medical markets outside of the dermatology market such as obesity and other potential markets where a topical or transdermal solution would be a viable alternative.

Biotech

News

Penny Stocks

Health Care

Movers

Trading Ideas

General

QNRX

SKVI

Why Are Quoin Pharma Shares Trading Higher Today?

Movers & Shakers

Intraday Update

Markets

ABMD

ACRGF

ADMP

ADMS

ADTN

AERI

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ARDS

ARGGY

ASASF

ASBFY

AUPH

AVCO

AVEW

AXAS

AXDDF

AXGN

AZRX

BCUCY

BEAT

BHKLY

BIEI

BKEAY

BLOZF

BLUU

BTHCF

BYDDY

CARG

CBAY

CDTI

CERS

CHKDP

CHYHY

CLLS

CMPNF

CMVLF

CNPOF

CNSL

CNTMF

CPPMF

CRSXF

CRUUF

CTAIF

CTEQF

CTRA

CTST

CTXR

CXXIF

DERM

DFILF

DMPI

DSFGY

DXBRF

DYMEF

EEGI

EEVVF

ENOB

ESTR

EUUNF

EXXAY

FFXXF

FIXX

FLDM

FLWPF

FRLI

FSSN

FUTL

GEMP

GLMD

GORAF

GYNAF

HABT

HCAT

HEXO

HITIF

HOTH

HSNGY

HTBX

ICPT

IPWR

IRNC

JASN

JCAP

JSHLY

KOPN

KPCPY

KWBT

LBRT

LEMIF

LYFT

MAKSY

Stocks That Hit 52-Week Lows On Thursday

Skinvisible Inc

Press Releases

Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome

Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment

Skinvisible Expands Obesity Patent Application for Transdermal Delivery

Skinvisible Unveils Promising Data on Transdermal Obesity Formulations

Promising Data on Transdermal Obesity Formulations Announced by Skinvisible

Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

Skinvisible

Comments

Skinvisible

Skinvisible (SKVI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga